Senseonics Holdings (SENS) Non Operating Investment Income (2021 - 2026)
Senseonics Holdings' (SENS) quarterly Non Operating Investment Income came in at -$61000.0 in Q1 2026, down 1933.33% year-on-year from $3327.3 in Q1 2025, and down 221.05% on a QoQ basis from -$19000.0 in Q4 2025.
Senseonics Holdings (SENS) Non Operating Investment Income (2021 - 2026) Analysis & Trends
Senseonics Holdings (SENS) has 6 years of Non Operating Investment Income data on file, last reported at -$61000.0 in Q1 2026.
- On a quarterly basis, Non Operating Investment Income fell 1933.33% year-over-year to -$61000.0 in Q1 2026; TTM through Mar 2026 was $11000.0, a 1200.0% increase from a year earlier, with the FY2025 full-year figure at $69000.0, up 527.27% from the prior year.
- Non Operating Investment Income for Q1 2026 stood at -$61000.0, down from -$19000.0 in the prior quarter.
- Over the last five years, Non Operating Investment Income for SENS reached as high as $507000.0 in Q4 2022 and fell as low as -$625000.0 in Q1 2022.
- Historically, Non Operating Investment Income has averaged $12941.2 across 5 years, with a median of $9000.0 in 2024.
- Across the five-year window, Non Operating Investment Income soared 620.0% in 2025 and plunged 1933.33% in 2026, its largest moves.
- Year by year, Non Operating Investment Income stood at $507000.0 in 2022, then plunged by 90.53% to $48000.0 in 2023, then tumbled by 170.83% to -$34000.0 in 2024, then soared by 44.12% to -$19000.0 in 2025, then sank by 221.05% to -$61000.0 in 2026.
- Per Business Quant data, the three most recent Non Operating Investment Income figures were -$61000.0 in Q1 2026, -$19000.0 in Q4 2025, and $65000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Senseonics Holdings | 229.57 Mn | 165.25 Mn | 6.94 Mn | -61,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -61,000.00 |
| Mar 31, 2026 | -61,000.00 |
| Dec 31, 2025 | -19,000.00 |
| Dec 31, 2025 | -19,000.00 |
| Sep 30, 2025 | 65,000.00 |
| Sep 30, 2025 | 65,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Mar 31, 2025 | -3,000.00 |
| Mar 31, 2025 | -3,000.00 |
| Dec 31, 2024 | -34,000.00 |
| Dec 31, 2024 | -34,000.00 |
| Sep 30, 2024 | 41,000.00 |
| Sep 30, 2024 | 41,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Mar 31, 2024 | 9,000.00 |
| Mar 31, 2024 | 9,000.00 |
| Dec 31, 2023 | 48,000.00 |
| Dec 31, 2023 | 48,000.00 |